enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. NC coverage of obesity drugs ends April 1. Here are alternatives.

    www.aol.com/nc-coverage-obesity-drugs-ends...

    A study on Wegovy found that 86% of people who took it lost at least 5% of their body weight. ... Orlistat requires prior authorization (meaning health care providers must obtain advance approval ...

  3. Semaglutide - Wikipedia

    en.wikipedia.org/wiki/Semaglutide

    Neither the participant nor the health care provider knew which treatment was being given. [29] Treatment was given for 104 weeks (2 years), and the occurrence of cardiovascular events, including heart attacks, strokes, and hospitalization due to unstable angina (near heart attack) were recorded and compared in the two groups of participants.

  4. Some doctors are embracing compounded versions of popular ...

    www.aol.com/news/doctors-embracing-compounded...

    Some health care providers say they’re starting to feel more comfortable prescribing compounded versions of the blockbuster weight loss drugs Wegovy and Zepbound, even as others have lingering ...

  5. Prior authorization - Wikipedia

    en.wikipedia.org/wiki/Prior_authorization

    Prior authorization, or preauthorization, [1] is a utilization management process used by some health insurance companies in the United States to determine if they will cover a prescribed procedure, service, or medication.

  6. Does Medicare cover Ozempic? Yes — but it depends on your Rx

    www.aol.com/finance/does-medicare-cover-ozempic...

    Will Medicare pay for Wegovy for weight loss? Wegovy can be covered by Medicare as of March 2024 if it’s used to treat or prevent heart attacks and strokes in people who are diagnosed as overweight.

  7. Utilization management - Wikipedia

    en.wikipedia.org/wiki/Utilization_management

    Utilization management is "a set of techniques used by or on behalf of purchasers of health care benefits to manage health care costs by influencing patient care decision-making through case-by-case assessments of the appropriateness of care prior to its provision," as defined by the Institute of Medicine [1] Committee on Utilization Management by Third Parties (1989; IOM is now the National ...

  8. GLP-1 receptor agonist - Wikipedia

    en.wikipedia.org/wiki/GLP-1_receptor_agonist

    In the United States, cost is the highest barrier to GLP-1 agonist usage and was reported as the reason for discontinuation in 48.6% of U.S. patients who stopped using the drugs. [40] According to another study, GLP-1 agonists are not cost-effective for pediatric obesity in the U.S. [ 41 ]

  9. GLP-1s shows how quickly health care can turn into a gold rush

    www.aol.com/finance/ozempic-wegovy-trimming...

    The GLP-1 phenomenon is making the fragmentation and dysfunction of the U.S. health care system even more apparent. Ozempic and Wegovy are trimming waistlines—and showing how quickly U.S. health ...